# FDA Inspection 1191175 - Octapharma Plasma Inc - November 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/93b8dcf0-e060-4736-8f91-a3837364c425
Source feed: FDA_Inspections

> FDA Inspection 1191175 for Octapharma Plasma Inc on November 02, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191175
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191175 - 2022-11-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/c3560add-cf43-4d64-8624-c9e37916bca2)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/6bef4cbe-19e9-467e-84b9-cc94d169e3df

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d